Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
home:patients:cohort_statistics [03.12.2019]
sallieq [Later information 2013]
home:patients:cohort_statistics [08.31.2019]
sallieq [Statistics on the Marshall Protocol]
Line 4: Line 4:
 ====== Statistics on the Marshall Protocol ​    ​====== ====== Statistics on the Marshall Protocol ​    ​======
  
-The primary function of the Marshall Protocol (MP) study site is to learn how the MP affects and improves the health of patients with a variety of inflammatory conditions. As of February 2009, there are about 1,000 patients who post in their progress reports on the MP study site. Many patients have recovered sufficiently to rejoin the work force, and subsequently become so busy that they no longer report progress. Autoimmunity Research Foundation is currently in the process of partnering with a hospital which has the resources necessary to manage a large-scale cohort study of the MP. +The primary function of the Marshall Protocol (MP) study site is to learn how the MP affects and improves the health of patients with a variety of inflammatory conditions. As of February 2009, there are about 1,000 patients who post in their progress reports on the MP study site. Most patients have recovered sufficiently to rejoin the work force, and subsequently become so busy that they no longer report progress. Autoimmunity Research Foundation is currently in the process of partnering with a hospital which has the resources necessary to manage a large-scale cohort study of the MP. 
  
 ===== Response rate ===== ===== Response rate =====
Line 14: Line 14:
 The best data collected thus far (//as at 2010//) is from a 2008 survey of MP patients with autoimmune diseases, the methodology of which is [[home:​publications:​mp2008_survey|described here]]. That data was presented by Capt. Tom Perez, MPH, at the [[home:​publications:​perez_congress_on_autoimmunity_2008|2008 International Congress on Autoimmunity]]. The best data collected thus far (//as at 2010//) is from a 2008 survey of MP patients with autoimmune diseases, the methodology of which is [[home:​publications:​mp2008_survey|described here]]. That data was presented by Capt. Tom Perez, MPH, at the [[home:​publications:​perez_congress_on_autoimmunity_2008|2008 International Congress on Autoimmunity]].
  
-ARF is currently in the process of partnering with a hospital which has the resources necessary to manage a large-scale cohort study of the MP.  
  
 ==== Later information 2013 ==== ==== Later information 2013 ====
  
-//from DJ in California.//+//from DJ in California//​
  
 <​blockquote>​Almost a year ago (February 2013)  I was on this discussion topic with others. I am retired and have a lot of time on my hands, so I did some work as a member who cares. ​ I have been waiting since August for the results of my 6 weeks of work to be released on this site, and have not seen anything. <​blockquote>​Almost a year ago (February 2013)  I was on this discussion topic with others. I am retired and have a lot of time on my hands, so I did some work as a member who cares. ​ I have been waiting since August for the results of my 6 weeks of work to be released on this site, and have not seen anything.
home/patients/cohort_statistics.txt · Last modified: 08.31.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.